Great Wisdom October 28th | Cisen Pharmaceutical (603367.SH) released the third quarter report, with revenue of 3 billion yuan in the first three quarters, a 6.47% year-on-year decrease, net income of 0.398 billion yuan, an increase of 1.97% year-on-year, non-net income of 0.363 billion yuan, a 2.49% year-on-year decrease, and basic earnings per share of 0.88 yuan.
辰欣药业(603367.SH):前三季净利润3.98亿元 同比增长1.97%
Cisen Pharmaceutical (603367.SH): The net income for the first three quarters was 0.398 billion yuan, an increase of 1.97% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.